Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HNST | EL |
|---|---|---|
| Price | $4.93 | $93.30 |
| Change today | ▲ 0.09% | ▼ 1.22% |
| Market cap | $529.36M | $33.80B |
| Return, 3 months | +24.6% | +14.2% |
| Return, year to date | +91.2% | -10.0% |
| Return, 1 year | +27.2% | -1.2% |
| P/E (TTM) | -44.9 | 186.6 |
| P/B | 3.2 | 8.9 |
| P/E percentile vs own 5y | 18th | 98th |
| Dividend yield | – | 1.50% |
| Revenue growth (YoY, latest qtr) | -10.9% | +6.3% |
| Net profit growth (YoY) | +176.1% | +78.8% |
| Gross margin | 35.7% | 75.5% |
| Operating margin | -3.1% | 11.1% |
| Net margin | -3.6% | 1.2% |
| Return on equity | -6.9% | 4.7% |
| Analyst target vs. price | +5.4% | +18.3% |
| Analyst buy share | 67% | 53% |
| RSI (14) | 39 | 49 |
| 30-day volatility | 35.4% | 31.1% |
| Max drawdown, 1 year | -47.1% | -43.6% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
